Anna Gazumyan

21.0k citations
61 papers · 5.2k indexed · 1 hit paper · h-index 38

Anna Gazumyan

59 papers receiving 5.1k citations

Hit Papers

Enhanced SARS-CoV-2 neutralization by dimeric IgA294202020262022202450100150200250

Peers

Anna Gazumyan
Comparison fields: 5 of 103
  • Virology 1.4k
  • Immunology 2.5k
  • Infectious Diseases 1.5k
  • Parasitology 434
  • Radiology, Nuclear Medicine and Imaging 734
Replace Ali Salanti with:
Ali Salanti Denmark
Hideto Kaneshima United States
Frances Gotch United Kingdom
Dorotheé von Laer Germany
Jean Boyer United States
Christine Trumpfheller United States
Gunilla B. Karlsson Hedestam Sweden
Gerd Sutter Germany
Elaine K. Thomas United States
J. Charles Whitbeck United States
Anna Gazumyan relative to Ali Salanti Denmark Ali Salanti's profile →
Citations per field
00.5×
Ali Salanti · 1×
Citations per year

Countries citing papers authored by Anna Gazumyan

Since Specialization
Citations

This map shows the geographic impact of Anna Gazumyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Gazumyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Gazumyan more than expected).

Fields of papers citing papers by Anna Gazumyan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Gazumyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Gazumyan. The network helps show where Anna Gazumyan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Anna Gazumyan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anna Gazumyan Line = papers co-authored together Anna Gazumyan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20250
3 20246
4 202312
5 20231
6 202249
7 2020157
8 202012
9 201971
10 201883
11 201826
12 201795
13 2016264
14 2016134
15 2016120
16 201698
17 201535
18 2010115
19 2010286
20 2006117

About Anna Gazumyan

Anna Gazumyan is a scholar working on Virology, Immunology and Infectious Diseases, having authored 61 papers that have together received 5.2k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (26 papers), T-cell and B-cell Immunology (25 papers), HIV Research and Treatment (16 papers), Immunotherapy and Immune Responses (9 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), DNA Repair Mechanisms (7 papers), Cytomegalovirus and herpesvirus research (6 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). The work is most often cited by research in Virology (1.4k citations), Immunology (2.5k citations) and Infectious Diseases (1.5k citations). Anna Gazumyan has collaborated with scholars based in United States, Germany and Cuba. Frequent co-authors include Michel C. Nussenzweig, Davide F. Robbiani, Ira Schwartz, Michael S. Seaman, Jovana Golijanin, John J. Schwartz, Mila Janković, Kevin M. McBride, Stylianos Bournazos and Jeffrey V. Ravetch. Their work appears in journals such as Nature, Science and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026